tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

C4 Therapeutics Inc

CCCC
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
3.310USD
+0.010+0.30%
์ข…๊ฐ€ย 09-22 16:00๏ผˆET๏ผ‰
365.99M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
์žฅ์ „ ๊ฑฐ๋ž˜ย 04:10ย (ET)3.270USD-0.040-1.21%

C4 Therapeutics Inc

3.310
+0.010+0.30%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

CCCC ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด C4 Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
365.99M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-3.03
์ฃผ๋‹น์ˆœ์ด์ต
-1.09
์ˆ˜์ต
35.95M
์ˆœ์ด์ต
-105.32M
ROE
-48.35%
ROA
-32.02%

C4 Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 11, 2026
EPS / ์˜ˆ์ƒ
-0.18/-0.23
์ˆ˜์ต / ์˜ˆ์ƒ
6.64M/4.00M

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
50.65%-0.18
46.36%-0.20
-158.70%-1.27
-25.13%-0.44
-42.33%-0.37
10.33%-0.37
27.80%-0.49
35.52%-0.35
64.84%-0.26
41.57%-0.41
10.71%-0.68
---0.55
---0.73
---0.71
---0.76
----
----
----
----
----
์ˆ˜์ต
2.75%6.64M
-15.00%6.15M
112.79%11.02M
-26.90%11.23M
-46.17%6.46M
138.17%7.24M
58.75%5.18M
38.75%15.36M
350.68%12.01M
-19.15%3.04M
14.26%3.26M
63.93%11.07M
-80.74%2.66M
-50.89%3.76M
-85.79%2.85M
-20.54%6.75M
41.44%13.83M
3.07%7.65M
143.02%20.08M
0.63%8.50M
์ˆœ์ด์ต
9.17%-23.64M
4.53%-25.13M
40.75%-20.49M
-30.41%-32.17M
-46.87%-26.02M
7.19%-26.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
-50.78%-31.62M
-36.97%-15.66M
8.74%-24.68M
์ˆœ์ด์ต๋ฅ 
11.60%-355.90%
-12.32%-408.47%
56.26%-292.08%
-78.39%-286.43%
-172.84%-402.60%
61.03%-363.66%
37.34%-667.82%
34.25%-160.57%
89.06%-147.56%
-0.86%-933.23%
18.20%-1065.75%
---244.19%
---1348.42%
---925.25%
---1302.91%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
-100.00%0.00%
-100.00%0.00%
--0.00%
--2.76%
--2.75%
--2.67%
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
2.75%6.64M
-15.00%6.15M
112.79%11.02M
-26.90%11.23M
-46.17%6.46M
138.17%7.24M
58.75%5.18M
38.75%15.36M
350.68%12.01M
-19.15%3.04M
14.26%3.26M
63.93%11.07M
-80.74%2.66M
-50.89%3.76M
-85.79%2.85M
-20.54%6.75M
41.44%13.83M
3.07%7.65M
143.02%20.08M
0.63%8.50M
์˜์—… ์ด์ต
7.29%-26.42M
4.73%-27.79M
38.62%-23.14M
16.16%-23.68M
-32.92%-28.50M
2.08%-29.16M
-0.75%-37.71M
-1.57%-28.24M
42.92%-21.44M
17.79%-29.78M
2.26%-37.43M
14.41%-27.81M
-37.19%-37.57M
-15.49%-36.23M
-151.02%-38.29M
-33.95%-32.49M
-23.82%-27.38M
-52.95%-31.37M
19.30%-15.26M
-32.18%-24.25M
์ˆœ์ด์ต
9.17%-23.64M
4.53%-25.13M
40.75%-20.49M
-30.41%-32.17M
-46.87%-26.02M
7.19%-26.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
-50.78%-31.62M
-36.97%-15.66M
8.74%-24.68M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
16.99%262.90M
5.52%245.37M
0.13%258.11M
-24.29%206.86M
-18.59%224.73M
-16.83%232.53M
-4.95%257.77M
22.15%273.23M
0.60%276.04M
0.41%279.59M
-5.69%271.19M
-31.27%223.69M
-13.81%274.39M
-8.09%278.45M
-11.71%287.56M
-21.06%325.46M
-33.34%318.37M
-5.92%302.95M
-14.52%325.69M
97.34%412.29M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
8.53%48.25M
-33.25%27.25M
-26.88%33.03M
-16.97%35.95M
-17.98%44.46M
-25.81%40.82M
5.64%45.18M
43.02%43.29M
12.36%54.20M
39.71%55.02M
-4.00%42.77M
-33.13%30.27M
4.53%48.24M
-16.19%39.38M
-13.07%44.55M
-7.02%45.27M
4.49%46.15M
24.79%46.99M
16.86%51.25M
21.69%48.69M
์ด ์ž์‚ฐ
21.20%359.40M
2.92%328.86M
2.71%359.07M
-29.40%265.49M
-22.19%296.53M
-19.79%319.52M
-7.13%349.60M
12.93%376.06M
1.62%381.09M
0.59%398.37M
-12.62%376.45M
-27.83%333.01M
-23.85%375.01M
-23.17%396.04M
-14.98%430.84M
-9.15%461.44M
-6.80%492.48M
37.83%515.49M
26.65%506.76M
121.67%507.91M
๋ถ€์ฑ„ ์ด๊ณ„
-8.43%112.14M
-23.93%94.61M
-23.30%102.49M
-16.73%111.08M
-8.63%122.46M
-11.21%124.38M
2.52%133.62M
14.03%133.40M
-5.14%134.03M
4.88%140.09M
-7.96%130.34M
-18.34%116.99M
-4.45%141.30M
-11.52%133.57M
20.87%141.61M
31.27%143.26M
32.04%147.88M
36.86%150.96M
-1.83%117.16M
-15.09%109.13M
์ž๋ณธ ์ด๊ณ„
42.05%247.26M
20.04%234.25M
18.80%256.59M
-36.37%154.41M
-29.55%174.06M
-24.45%195.14M
-12.24%215.99M
12.33%242.66M
5.71%247.06M
-1.60%258.28M
-14.91%246.11M
-32.11%216.02M
-32.18%233.71M
-28.00%262.47M
-25.76%289.23M
-20.21%318.18M
-17.25%344.59M
38.23%364.53M
38.75%389.61M
296.42%398.78M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
86.95%-1.57M
10.04%-29.94M
-23.49%-22.14M
-29.31%-31.21M
-142.40%-12.06M
-83.71%-33.28M
25.31%-17.93M
21.41%-24.13M
73.82%-4.97M
45.30%-18.12M
17.57%-24.01M
-9.59%-30.71M
14.41%-19.00M
-24.55%-33.13M
-13.47%-29.13M
-52.63%-28.02M
-23.29%-22.20M
-6.67%-26.60M
-19.18%-25.67M
-27.52%-18.36M
์ˆœํˆฌ์ž
-138.06%-14.81M
-44.54%16.15M
-690.59%-80.73M
2422.22%4.09M
432.49%38.92M
154.55%29.13M
-57.21%13.67M
-99.72%162.00K
-177.28%-11.71M
-199.75%-53.40M
244.09%31.95M
189.87%57.73M
-54.41%15.15M
1436.94%53.53M
115.63%9.28M
119.79%19.91M
2.45%33.23M
93.51%-4.00M
-9.58%-59.41M
-211.34%-100.63M
์ˆœ์žฌ๋ฌดํ™œ๋™
--33.73M
1104.35%462.00K
105857.14%118.67M
-26.01%7.77M
-100.00%0.00
-100.13%-46.00K
-99.81%112.00K
197.70%10.51M
118.10%135.00K
5155.99%34.58M
122606.38%57.67M
-3078.67%-10.75M
-388.03%-746.00K
-242.50%-684.00K
-89.91%47.00K
-38.18%361.00K
-99.85%259.00K
417.88%480.00K
-99.76%466.00K
-76.63%584.00K

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

C4 Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 35.95M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 35.58M์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 258.11M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 0.13์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, C4 Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 359.07M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.71์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, C4 Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 102.49M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -23.30์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, C4 Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 256.59M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 18.80์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, C4 Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -104.49M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 10.83์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, C4 Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” -8.60M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 83.22์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, C4 Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 126.40M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 178.80์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.27์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 16.57์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -104.99M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 0.31์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -292.08์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1.31์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -44.44์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.52์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -29.63์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -2.14์ž…๋‹ˆ๋‹ค.

C4 Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
C4 Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -104.49M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 10.83์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ